China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 50%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after a company apologized for earlier misleading investors on such treatments.

Apple’s Cook Cheers on Tencent Game Gala in Surprise China VisitAsia Stocks to Rise on Mideast Diplomacy Efforts: Markets WrapSaudi Savola Weighs $5.4 Billion Almarai Stake SaleSouth Africa Set to Topple Nigeria to Regain Mantle as Continent’s Biggest EconomyTSMC Drops Plan for Chip Plant After Reports of Local ProtestsLabour Investment Plans Could Deliver ‘Meaningful’ Boost for UKRBA Staff Consider Strike After Pay Talks Turn Sour, Union SaysSaudi Savola Weighs $5.

5B this year: PBOPharmacare would cost public sector billions more a year, but save economy money: PBOCanadians are cutting back on spending, RBC report showsRoyal LePage downgrades Q4 housing price forecast; expecting 7% increaseDurable goods to blame for inflation burst, no need for rate hike: reportBRI Latest: Forum for Xi’s Signature Project Starts in BeijingWhiskey Giant Chivas Looks to Push More Single Malts Into IndiaSpaceX Fights to Extend Ban on Regulating Commercial...

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 83. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し